Urogen Pharma Ltd at JPMorgan Healthcare Conference Transcript
Good afternoon. My name is Turner Kufe. I'm a biotech analyst here at JPMorgan. Our next presenting company is UroGen Pharma. And speaking on behalf of the company is CEO, Liz Barrett, and we'll have the breakout session in the Olympic Room afterwards for some Q&A. Thank you.
Great. Thanks, Turner, and thanks, JPMorgan, for having us here. I'm really pleased to be here. I will say, a lot happens in a year. For those of you who know or may not know, one year ago when I presented at JPMorgan, I was day 6 on the job. And -- but I did get through the presentation which was good, and sounding like maybe I knew a little bit about what I was talking about. So I'm really thrilled to be here today. I want to take an opportunity to share with you what an eventful year it has been for UroGen in 2019, but also what another eventful year it will be for us in 2020. I want to take an opportunity to recognize my
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
